Ocular penetration enhancers

Ophthalmic Drug Delivery Systems, Second Edition, Revised and Expanded

Volumn , Issue , 2003, Pages 281-307

  Lee, Thomas Wai Yip ^a   Robinson, Joseph R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899822967     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (63)

1. Sieg, J. W., and Robinson, J. R. Vehicle effects on ocular drug bioavailability. 1. Evaluation of fluorometholone. J. Pharm. Sci. 64: 931-936, 1975.
2. Patton, T. F., and Robinson, J. R., Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J. Pharm. Sci. 64: 1312-1316, 1975.
3. Robinson, J. R., and Mlynek, G. M. Bioadhesive and phase-change polymers for ocular drug delivery. Adv. Drug. Delivery Rev. 16: 45-50, 1995.
4. Salminen, L., and Urtti, H. Prolonged pulse-entry of pilocarpine with a soluble drug insert. Graefes Arch. Clin. Exp. Ophthalmol. 221: 96, 1983.
5. Worakul, N., and Robinson, J. R. Ocular pharmacokinetics/pharmacody-namics. Eur. J. Pharm. Biopharm. 44: 71-83, 1997.
6. Keister, J. C., Cooper, E. R., Missel, P. J., Lang, J. C., and Hager, D. F. Limits on optimizing ocular drug delivery. J. Pharm. Sci. 80: 50-53, 1990.
7. Harris, D., and Robinson, J. R. Bioadhesive polymers in peptide drug delivery. Biomaterials 11: 652-658, 1990.
8. Grass, G. M. Mechanisms of Corneal Drug Penetration. Ph.D. thesis, School of Pharmacy, University of Wisconsin-Madison, 1985.
9. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D. Molecular Biology of the Cell, 3rd ed., Garland Publishing, Inc., New York, 1994.
10. Liaw, J., and Robinson, J. R. Ocular penetration enhancers. In: Ophthalmic Drug Delivery Systems (Mitra A., ed.), Marcel Dekker, New York, 1993, pp. 369-381.
11. Rojanasakul, Y., and Robinson, J. R. Transport mechanisms of the cornea: Characterization of barrier permselectivity. Int. J. Pharm. 55: 237-246, 1989.
12. Lee, V. H. L., and Robinson, J. R. Review: Topical ocular drug delivery: Recent developments and future challenges. J. Ocular Pharmacol. 2: 67-108, 1986.
13. Robinson, J. R., and Yang, X. Absorption enhancers. In: Encyclopedia of Pharmaceutical Technology, Vol. 18 Swarbrick J. and Boylan J. C. (eds.), Marcel Dekker, New York, 1999, pp. 1-27.
14. Sasaki, H., Yamamura, K., Mukai, Nishida, K., Nakamura, J., Nakashima, M., and Ichikawa, M. Enhancement of ocular drug penetration, Crit. Rev. Drug Carrier Syst. 16: 85-146, 1999.
15. Junginger, H. E., and Verhoef, J. C. Macromolecules as safe penetration enhancers for hydrophilic drugs-a fiction? Pharmaceut. Sci. Technol. Today 1: 370-376, 1998.
16. Grass, G. M., Wood, R. W., and Robinson, J. R. Effects of calcium chelating agents on corneal permeability. Invest. Ophthalmol. Vis. Sci. 26: 110-113, 1985.
17. Rojanasakul, Y., Liaw, J. and Robinson, J. R. Mechanisms of action of some penetration enhancers in the cornea: laser scanning confocal microscopic and electrophysiological studies. Int. J. Pharm. 66: 131-142, 1990.
18. Nishihata, T., Tomida, H., Frederick, G., Rytting, J. H., and Higuchi, T. Comparison of the effects of sodium salicylate, disodium ethylenediamine tetraacetic acid and polyoxylene-23-lauryl ether as adjuvants for the rectal absorption of sodium cefoxitin. J. Pharm. Sci. 37: 159, 1985.
19. Frederiksen, O., and Leyssac, P. P. Effects of cytochalasin B. and dimethyl-sulsulfoxide on isoosmotic transport by rabbit gall-bladder in vitro. J. Facial (Lund.) 265: 103-118, 1977.
20. Madara, J. L., et al. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: Further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J. Cell Biol. 102: 2125, 1986.
21. Martinez-Palomo, A. Structure of tight junctions in epithelia with different permeability. Proc. Natl. Acad. Sci. USA 72: 4487-4491, 1975.
22. Lee, V. H. L., ed. Peptides and Proteins Drug Delivery. Marcel Dekker, New York, 1990.
23. Murakami, M., et al. Intestinal absorption enhanced by unsaturated fatty acids: Inhibitory effect of sulfhydryl modifiers. Biochim. Biophys. Acta293: 238, 1988.
24. Cyclodextrins in Pharmacy (Fromming, K.-H., and Szejtli, J., eds.), Kluwer Academic Publishers, Boston, 1994.
25. Davies, N. M., Wang, G., and Tucker, I. G. Evaluation of a hydrocortisone/hydroxypropyl-beta-cyclodextrin solution for ocular drug delivery. Int. J. Pharm. 156: 201-209, 1997.
26. Jarho, P., Jarvinen, K., Urtti, A., Stella, V. J., and Jarvinen, T. Use of cyclodextrins in ophthalmic formulations of dipivefrin. Int. J. Pharm. 153: 225-233, 1997.
27. Siefert, B., and Keipert, S. Influence of alpha-cyclodextrin and hydroxyalky-lated b-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions. J. Pharm. Sci. 86: 716-720, 1997.
28. Michniak, B. B., Player, M. R., Godwin, D. A., Lockhart, C. C., and Sowell, J. W. In vitro evaluation of azone analogs as dermal penetration enhancers. Part 5. Miscellaneous compounds. Int. J. Pharm. 161: 169-178, 1998.
29. Valenta, C., and Wedenig, S. Effects of penetration enhancer on the in vitro percutaneous absorption of progesterone. J. Pharm. Pharmacol. 49: 955-959, 1997.
30. Chatterjee, D. J., Li, W. Y., and Koda, R. T. Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin. Pharm. Res. 14: 1058-1065, 1997.
31. Tang-Liu, D. D-S., Richman, J. B., Weinkam, R. J., and Takruri, H. Effects of four penetration enhancers on corneal permeability of drugs in vitro. J. Pharm. Sci. 83: 85-90, 1994.
32. Tang-Liu, D. D.-S., and Burke, J. The effect of Azone® on ocular levobunolol absorption: Calculating the area under the curve and its standard error using tissue sampling compartments. Pharm. Res. 5: 238-241, 1988.
33. Ismail, I. M., Chen, C.-C., Richman, J. B., Andersen, J. S., and Tang-Liu, D. D.-S. Comparison of azone and hexamethylene lauramide in toxicological effects and penetration enhancement of cimetidine in rabbit eyes. Pharm. Res. 9: 817-821, 1992.
34. Chiou, G. C. Y., Chang, C. Y., and Chang, M. S. Systemic delivery of insulin through eyes to lower the glucose concentration. J. Ocular Pharmacol. 5: 8191, 1989.
35. Pillion, D. J., Atchison, J. A., Stott, J., McCracken, D. L., Gargiulo, C., and Meezan, E. Efficacy of insulin eyedrops. J. Ocular Pharmacol. 10: 461-470, 1994.
36. Pillion, D. J., McCracken, D. L., Yang, M., and Atchison, J. A. Glucagon administration to the rat via eye drops. J. Ocular Pharmacol. 4: 349-358, 1992.
37. Pillion, D. J., Amsden, J. A., Kensil, C. R., and Recchia, J. Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin. J. Pharm. Sci. 85: 518-524, 1996.
38. Morgan, R. V. Delivery of systemic regular insulin via the ocular route in cats. J. Ocular Pharmacol. 11: 565-573, 1995.
39. Morgan, R. V., and Huntzicker, M. A. Delivery of systemic regular insulin via the ocular route in dogs. J. Ocular Pharmacol. 12: 515-526, 1996.
40. Steiner, S., and Rosen, R. Delivery System for Pharmacological Agents Encapsulated Proteinoids. U.S. Patent, 1990.
41. Wu, S.-Y. Mechanistic studies on the enhanced mucosal transport of human growth hormone by certain amino acid derivatives. Ph.D. thesis, School of Pharmacy, University of Wisconsin-Madison, 1999.
42. Leone-Bay, A., Mclnnes, C., Wang, N., DeMorin, F., Achan, D., Lercara, C., Sarubbi, D., Haas, S., Press, J., Barantsevich, E., O’Broin, B., Milstein, S., and Patron, D. Microsphere formation in a series of derivatized a-amino acids: Properties, molecular modeling, and oral delivery of salmon calcitonin. J. Med. Chem. 38: 4257-4262, 1995.
43. Leone-Bay, A., Santiago, N., Achan, D., Chaudhary, K., DeMorin, F., Falzarano, L., Haas, S., Kalbag, D., Leipold, H., Lercara, C., O’Toole, D., Rivera, T., Rosado, C., Sarubbi, D., Vuocolo, E., Wang, N., Milstein, S., and Baughman, R. A. N-acylated a-amino acids as novel oral delivery agents for proteins. J. Med. Chem. 38: 4263-4269, 1995.
44. Brayden D., Creed E., O’Connell A., Leipold, H., Lercara C., Agarwal R., and Leone-Bay A. Heparin absorption across the intestine: Effects of sodium N-[8(2-hydroxybenzoyl)amino]caprylate in Caco-2 monolayers and in rat in situ intestinal instillations. Pharm. Res. 14: 1772-1779, 1997.
45. Leone-Bay, A., Ho, K., Agarwal, R., Baughman, R. A., Chaudhary, K., DeMorin, F., Genoble, L., Mclnnes, C., Lercara, C., Milstein, S., O’Toole, D., Sarubbi, D., Variano, B., and Paton, D. R. 4-[4-[(2-Hydroxybenzoyl)amino]phenyl]butyric acid as a novel oral delivery agent for recombinant human growth hormone. J. Med. Chem. 39: 2571-2578, 1996.
46. Robinson, J. R., unpublished data, 1998.
47. Yen, W.-C., and Lee, V. H. L. Paracellular transport of a proteolytically labile pentapeptide across the colonic and other intestinal segments of the albino rabbit: Implications for peptide drug design. J. Contr. Rel. 28: 97-109, 1994.
48. Yen, W.-C., and Lee, V. H. L. Penetration enhancement effect of Pz-peptide, a paracellularly transported peptide, in rabbit intestinal segments and Caco-2 cell monolayers. J Contr. Rel. 36: 25-37, 1995.
49. Chung, Y. B., Han, K., Nishiura, A., and Lee, V. H. L. Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit. Pharm. Res. 15: 1882-1887, 1998.
50. Yen, W.-C., and Lee, V. H. L. Role of Na+ in the asymmetric paracellular transport of 4-phenylazobenzyloxycarbonyl-L-Pro-L-Leu-Gly-L-Pro-D-Arg across rabbit colonic segments and Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. J. Contr. Rel. 36: 25-37, 275: 114-119, 1995.
51. Saha, P., Yang, J., and Lee, V. H. L. Existence of a P-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest. Ophthalmol. Vis. Sci. 39: 1221-1226, 1998.
52. Zimmer, A., and Kreuter, J. Microcapsules and nanoparticles used in ocular delivery systems. Adv. Drug Delivery Rev. 16: 61-73, 1995.
53. Calvo, P., Alonson, M. J., Vila-Jato, J. L., and Robinson, J. R. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J. Pharm. Pharmacol. 48: 1147-1152, 1996.
54. Yang, X., and Robinson, J. R. Bioadhesion in mucosal drug delivery. In: Biomaterials for Drug Delivery (Okano, T., ed.), Elsevier, Amsterdam, 1998.
55. Morimoto, K., Iwamoto, T., and Morisaka, K. Possible mechanisms for the enhancement of rectal absorption of hydrophilic drugs and polypeptides by aqueous polyacrylic acid gel. J. Pharmacobio-Dyn. 10: 85-91, 1987.
56. Kriwet, B., and Kissel, T. Interactions between bioadhesive poly(acrylic acid) and calcium ions. Int. J. Pharm. 127: 135-145, 1996.
57. LuBen, H. L., Bohner, V., Pe’rard, D., Langguth, P., Verhoef, J. C., de Boer, A. G., Merkle, H. P., and Junginger, H. E. Mucoadhesive polymers in peroral peptide drug delivery: V. Effect of poly(acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles. Int. J. Pharm. 141: 39, 1996.
58. Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15: 1326-1331, 1998.
59. Yoshiaki, K., Yamamoto, H., Takeuchi, H., and Kuno, Y. Mucoadhesive dl-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery elcatonin. Pharm. Dev. Tech. 5: 77-85, 2000.
60. Felt, O., Furrer, P., Mayer, J. M., Plazonnet, B., Buri, P., and Gurny, R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int. J. Pharm. 180: 185-193, 1999.
61. Dodane, V., Khan, A. M., and Merwin, J. R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182: 21-32, 1999.
62. Bernkop-Schnurch, A., Paikl, C., and Pasta, M. Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopep-tidase N. Pharm. Res. 14: 917-922, 1997.
63. Bernkop-Schnurch, A., and Pasta, M. Intestinal peptide and protein delivery: Novel bioadhesive drug-carrier matrix shielding from enzymatic attack. J. Pharm. Sci. 87: 430-434, 1998.